Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

E 1040

Known as: E-1040, E1040 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

cefclidin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum.
SCE-2787, a new cephalosporin having a condensed azolium moiety in the 3 position and an aminothiadiazolyl group in the 7 beta… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
1992
1992
Synthesis and structure-activity relationships of a new series of cephalosporins, E1040 and related compounds.
The synthesis and in vitro antibacterial activity of a series of 7-[(Z)-2-aminoaryl-2-oxyiminoacetamido]-3-ammoniomethyl++ +-3… Expand
1992
1992
Bactericidal activity of cefclidin (E1040) against Pseudomonas aeruginosa under conditions simulating plasma pharmacokinetics: lack of development of chromosomally-mediated resistance to beta-lactams…
The bactericidal activity of cefclidin (E1040), a new cephalosporin, against Pseudomonas aeruginosa was compared with that of… Expand
1992
1992
Role of the aminothiadiazolyl group in the antipseudomonal activity of cefclidin.
Cefclidin (E1040), which has an aminothiadiazolyl group in the 7 beta-side chain, showed about four-fold higher activity against… Expand
  • table 1
  • table 2
  • table 4
  • table 5
  • figure 2
1991
1991
Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems.
E-1040, a new parenteral fourth-generation cephalosporin, was tested against greater than 600 bacteremic pathogens and compared… Expand
Highly Cited
1990
Highly Cited
1990
Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases.
Seven extended-spectrum beta-lactamases related to TEM and four enzymes derived from SHV-1 were transferred to a common… Expand
  • table 1
  • table 2
  • table 3
  • table 5
  • table 6
1990
1990
In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum.
On the basis of preliminary in vitro data, we evaluated E-1040, a new cephalosporin, against 188 cystic fibrosis (CF) sputum… Expand
  • table 1
  • figure 1
1990
1990
In-vitro and in-vivo antibacterial activities of E1040, a new cephalosporin with potent antipseudomonal activity.
E1040 is a new parenteral cephalosporin with a broad antibacterial spectrum and potent activity against Gram-negative bacteria… Expand
1988
1988
In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
E1040 is a new parenteral cephalosporin with a broad antibacterial spectrum and potent antipseudomonal activity. The compound was… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
1988
1988
In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa.
The in vitro activity of E-1040 [(6R,7R)-3-[(4-carbamoyl-1-quinuclidinio)methyl]-7-[2-(5-amino-1,2 ,4- thiadiazol-3-yl)-(Z)-2… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE